In last trading session, Olink Holding AB (publ) (NASDAQ:OLK) saw 0.16 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $22.08 trading at -$1.91 or -7.96% at ring of the bell on the day assigns it a market valuation of $2.56B. That closing price of OLK’s stock is at a discount of -12.91% from its 52-week high price of $24.93 and is indicating a premium of 62.0% from its 52-week low price of $8.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.16 million shares which gives us an average trading volume of 123.16K if we extend that period to 3-months.
For Olink Holding AB (publ) (OLK), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.30. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.09 in the current quarter.
Olink Holding AB (publ) (NASDAQ:OLK) trade information
Upright in the red during last session for losing -7.96%, in the last five days OLK remained trading in the red while hitting it’s week-highest on Monday, 11/21/22 when the stock touched $22.08 price level, adding 11.43% to its value on the day. Olink Holding AB (publ)’s shares saw a change of 21.32% in year-to-date performance and have moved -3.24% in past 5-day. Olink Holding AB (publ) (NASDAQ:OLK) showed a performance of 20.59% in past 30-days. Number of shares sold short was 4.35 million shares which calculate 32.44 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $20.00 to the stock, which implies a fall of -10.4% to its current value. Analysts have been projecting $16.00 as a low price target for the stock while placing it at a high target of $27.00. It follows that stock’s current price would drop -22.28% in reaching the projected high whereas dropping to the targeted low would mean a gain of 27.54% for stock’s current value.
Olink Holding AB (publ) (OLK) estimates and forecasts
Statistics highlight that Olink Holding AB (publ) is scoring comparatively higher than the scores of other players of the relevant industry. The company added 96.09% of value to its shares in past 6 months, showing an annual growth rate of 69.77% while that of industry is -4.60. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to decrease by -80.00% in the current quarter and calculating 100.00% increase in the next quarter. This year revenue growth is estimated to rise 49.20% from the last financial year’s standing.
2 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $28.96 million for the same. And 2 analysts are in estimates of company making revenue of $62.24 million in the next quarter that will end on Dec 2022.
Olink Holding AB (publ) is more likely to be releasing its next quarterly report on November 10 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Olink Holding AB (publ) (NASDAQ:OLK)’s Major holders
Insiders are in possession of 69.81% of company’s total shares while institution are holding 39.24 percent of that, with stock having share float percentage of 129.98%. Investors also watch the number of corporate investors in a company very closely, which is 39.24% institutions for Olink Holding AB (publ) that are currently holding shares of the company. FMR, LLC is the top institutional holder at OLK for having 12.65 million shares of worth $192.29 million. And as of Jun 29, 2022, it was holding 10.62% of the company’s outstanding shares.
The second largest institutional holder is Price (T.Rowe) Associates Inc, which was holding about 9.67 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 8.12% of outstanding shares, having a total worth of $147.0 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Price (T.Rowe) Health Sciences Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 2.0 million shares of worth $30.33 million or 1.68% of the total outstanding shares. The later fund manager was in possession of 1.94 million shares on Jun 29, 2022, making its stake of worth around $29.54 million in the company or a holder of 1.63% of company’s stock.